Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion.

Eli Lilly is vulnerable to them. That being said, the analyst was clearly impressed by the company's momentum with Zepbound. His research indicates that it's notably pulling ahead of Novo Nordisk ...

LLY has delivered impressive returns of 15% year-to-date (as of April 30), outperforming the S&P 500’s 5% decline during the ...

Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...

J&J, Eli Lilly, Pfizer, Merck, Amgen are included in this Analyst Blog ... To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Eli Lilly (NYSE:LLY) harnessed significant operational performance during the latest quarter, reporting robust sales and net ...

Indianapolis-based Eli Lilly and Co. on Thursday posted 45% revenue growth in the first quarter of 2025 that topped Wall Street expectations, but stock prices tumbled more than 10% by midday after ...

Eli Lilly's stock ... BMO Capital Markets analyst Evan Seigerman said, per Reuters. Additionally, no liver-related safety signal was observed in the trial, Lilly said. Lilly's new pill can be ...

Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) stock cut his price target on the pharmaceutical giant. Even though that ...